🟢 Illumina is trading 4.5% up today, with RBC’s higher target a possible catalyst

Illumina is trading 4.51% higher at $306.93 on October 6, with RBC Capital’s target increase a likely company-specific catalyst; its direct role is unconfirmed.

• Illumina gained 7.56% in the previous session. U.S. indexes also rose, with the Nasdaq up 1.05%.
• On October 5, RBC Capital raised its price target to $310 from $230, maintained an Outperform rating, and cited a clinical-sales inflection and positive catalysts.
• No separate October 6 company announcement was identified in available coverage.